Eckert & Ziegler SEXTER:EUZ -0.26%98 Gross Margin % is 49.37% as of Mar. 2026, which is 2% above its 10-year median of 48.57. GuruFocus rates XTER:EUZ with a GF Score™ of 98/100 and a GF Value™ of €16.25 (Fairly Valued). Among 805 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks worse than 54.78% on this metric.
The historical rank and industry rank for Eckert & Ziegler SE's Gross Margin % or its related term are showing as below:
XTER:EUZ'
s Gross Margin % Range Over the Past 10 Years
Min: 44.07 Med: 48.57 Max: 50.48
Current: 48.91
During the past 13 years, the highestGross Margin % of Eckert & Ziegler SE was 50.48%. The lowest was 44.07%. And the median was 48.57%.
XTER:EUZ's Gross Margin % is ranked worse than 54.78% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs XTER:EUZ: 48.91
Eckert & Ziegler SE had a gross margin of 49.37% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Eckert & Ziegler SE was -0.50% per year.
Eckert & Ziegler SE (XTER:EUZ) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Eckert & Ziegler SE had a gross margin of 49.37% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Eckert & Ziegler SE Gross Margin % Related Terms
Eckert & Ziegler SE Gross Margin % Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:EUZ vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Eckert & Ziegler SE's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Eckert & Ziegler SE (XTER:EUZ) has a Gross Margin % of 49.37% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Eckert & Ziegler SE and its competitors. This is near median its historical median of 48.57. Over the past decade, Eckert & Ziegler SE's Gross Margin % has ranged from 44.07 to 50.48. According to the industry distribution chart, Eckert & Ziegler SE ranks #441 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 54.8%.
Is Eckert & Ziegler SE's Gross Margin % too high?
Eckert & Ziegler SE's current Gross Margin % of 49.37% is near median its 10-year median of 48.57. Over the past 10 years, this metric has ranged from a low of 44.07 to a high of 50.48. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Eckert & Ziegler SE's value of 49.37% is 4.9% below this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #441 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #441 out of 805 companies for Gross Margin %. This places Eckert & Ziegler SE in the lower half of its industry. The industry median Gross Margin % is 51.94. Eckert & Ziegler SE's value of 49.37% is 4.9% below this benchmark. Historically, Eckert & Ziegler SE's own Gross Margin % has ranged from 44.07 to 50.48 over the past decade. While the company's 10-year median is 48.57 vs. the industry median of 51.94, Eckert & Ziegler SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current Gross Margin % of 49.37% is 4.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current Gross Margin % is 49.37%, which is near median its own 10-year median of 48.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (XTER:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.25, compared to a current price of €15.27 — trading 6% below its estimated fair value. The current Gross Margin % is 49.37%, which is near median its 10-year median of 48.57 and 4.9% below the Medical Devices & Instruments industry median of 51.94. Eckert & Ziegler SE's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Eckert & Ziegler SE (XTER:EUZ), the current Gross Margin % is 49.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.27 is trading 6% below its estimated GF Value™ of €16.25.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for XTER:EUZ:
Gross Margin %: 49.37% (near median its 10-year median of 48.57)
GF Value™: €16.25 vs. price of €15.27 (6% below fair value)
Industry Position: 4.9% below the Medical Devices & Instruments median (#441 of 805)
No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score
Get the complete analysis for XTER:EUZ
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:EUZ has been successfully added to your 
